Aaron Lorenzo

Drug manufacturing issues caused investors to dump shares of Discovery Laboratories Inc., dropping the company's stock price by 22 percent Tuesday. (BioWorld Today)

Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

Feb. 2, 2005

By Aaron Lorenzo

Drug manufacturing issues caused investors to dump shares of Discovery Laboratories Inc., dropping the company's stock price by 22 percent Tuesday. (BioWorld Today)

$12M Private Funding To Help CepTor Push Myodur Program

Feb. 1, 2005

By Aaron Lorenzo

Aaron Lorenzo

ARTICLES

NIH Has New Ethics Rules; Ripples Could Hurt Agency

Xcyte's Shares Slump As FDA Seeks To Rework Trial Plans

Xcyte's Shares Slump As FDA Seeks To Rework Trial Plans

FDA Approves Nascobal After Manufacturing Issues Solved

MEND Act Unveiled As Approach For Better Medicare Buying Power

MEND Act Unveiled As Approach For Better Medicare Buying Power

FDA Approves Nascobal After Manufacturing Issues Solved

Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

$12M Private Funding To Help CepTor Push Myodur Program

Today's news in brief

Brain’s hidden tau-clearing pathway uncovered

News in brief

MSD synthesizes α-synuclein PET agents

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent